{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:13:18Z","timestamp":1793945598980,"version":"4.8.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.1080\/10428194.2023.2256911","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:51:30Z","timestamp":1698069090000},"page":"2286-2295","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia"],"prefix":"10.1080","volume":"64","author":[{"given":"Scott F.","family":"Huntington","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"de Nigris","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Puckett","sequence":"additional","affiliation":[{"name":"COVIA Health Solutions, Lansdale, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kamal-Bahl","sequence":"additional","affiliation":[{"name":"COVIA Health Solutions, Lansdale, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Farooqui","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Ryland","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sarpong","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Leng","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Yang","sequence":"additional","affiliation":[{"name":"Merck &amp; Co., Inc., Rahway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalpa A.","family":"Doshi","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"American Cancer Society. What is chronic lymphocytic leukemia? [cited 2023 Jan 9]. Available from: https:\/\/www.cancer.org\/cancer\/chronic-lymphocytic-leukemia\/about\/what-is-cll.html"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.10.105"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-020-0715-5"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25638"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0602-x"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25436"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606038"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.182907"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.126672"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.171041"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-603670"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30596"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2014.218"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1449616"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1602268"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00870-w"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16922"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3855"},{"key":"e_1_3_2_20_1","unstructured":"Walker J. Patients struggle with high drug prices \u2013 WSJ [cited 2023 Jan 9]. Available from: https:\/\/www.wsj.com\/articles\/patients-struggle-with-high-drug-prices-1451557981"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.027896"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.7.669"},{"issue":"3","key":"e_1_3_2_23_1","first-page":"S39","article-title":"Reducing out-of-pocket cost barriers to specialty drug use under Medicare part D: addressing the problem of \u201ctoo much too soon\u201d","volume":"23","author":"Doshi JA","year":"2017","unstructured":"Doshi JA, Li P, Pettit AR, et\u00a0al. Reducing out-of-pocket cost barriers to specialty drug use under Medicare part D: addressing the problem of \u201ctoo much too soon\u201d. Am J Manag Care. 2017;23(3 Suppl):S39\u2013S45.","journal-title":"Am J Manag Care"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2856"},{"key":"e_1_3_2_25_1","unstructured":"Lymphoma Research Foundation. U.S. Food and Drug Administration approves acalabrutinib (CALQUENCE) for chronic lymphocytic leukemia\/small lymphocytic lymphoma. Lymphoma Research Foundation [cited 2022 Dec 8]. Available from: https:\/\/lymphoma.org\/news\/u-s-food-and-drug-administration-approves-acalabrutinib-calquence-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma\/"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2023.2256911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:07:16Z","timestamp":1727276836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2023.2256911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":24,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,12,6]]}},"alternative-id":["10.1080\/10428194.2023.2256911"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2023.2256911","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}